Shepard Jay

Shepard Jay is listed in filings as Director at Esperion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including 8 public disclosures. Recent filings connect the profile to Esperion Therapeutics, Inc. (ESPR), Inovio Pharmaceuticals, Inc. (INO), and Ironwood Pharmaceuticals, Inc. (IRWD). The current snapshot covers public activity from Jun 21, 2024 to Jun 1, 2026. Reported amounts are shown as $51.4K to $38.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.